Prevention of airsickness with meprobamate.

Prevention of airsickness with meprobamate. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Prevention of airsickness with meprobamate. Abstract Text:

Prevention of airsickness with meprobamate. Publishing Authors By Initials

For similar disorders of environmental origin: motion sickness research abstracts see: disorders of environmental origin: motion sickness research

PUBMED ID PMID:

MEDLINE DATE:

Prevention of airsickness with meprobamate. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Technical documentary report. SAM-TDR. USAF School

VOLUME: 62-56

Page Numbers: 3p

Journal Abbreviation:

ISSN:

DAY: 4

MONTH: Feb

YEAR: 1962

Prevention of airsickness with meprobamate. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 22410750

Prevention of airsickness with meprobamate. Keywords Mesh Terms:

KEYWORDS: Motion Sickness

MESH TERMS:

Chemical & Substance for Abstract: Prevention of airsickness with meprobamate. Information

Substance Name: Meprobamate

Registry Number: 57-53-4

Grant and Affiliation Information for Prevention of airsickness with meprobamate.

AFFILIATION:

Country: Not Available

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Tech Doc Rep SAMTDR USAF Sch A

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Prevention of airsickness with meprobamate Related Publications

• A controlled study of job strain in primary-treated cancer patients without metastases.
• A human health risk assessment for macrolide-resistant Campylobacter associated with the use of macrolides in Danish pig production.
• A novel splice site mutation in EYA4 causes DFNA10 hearing loss.
• A prospective study of patterns of fatigue in multiple sclerosis.
• Adverse patient reactions during orthodontic treatment with fixed appliances.
• Affect regulation, brain development, and behavioral/emotional health in adolescence.
• Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study.
• Alterations in reward-related decision making in boys with recent and future depression.
• Assignment of the gene locus for severe congenital neutropenia to chromosome 1q22 in the original Kostmann family from Northern Sweden.
• Attitudes and practices of pediatric oncology providers regarding fertility issues.
• CHF3381, a N-methyl-D-aspartate receptor antagonist and monoamine oxidase-A inhibitor, attenuates secondary hyperalgesia in a human pain model.
• Chop it, ChIP it, check it: the current status of chromatin immunoprecipitation.
• Concerns about infertility risks among pediatric oncology patients and their parents.
• HEMA reduces cell proliferation and induces apoptosis in vitro.
• In cyclosporine-induced neurotoxicity, is tacrolimus an appropriate substitute or is it out of the frying pan and into the fire?-Response.
• Measuring changes in client-level treatment process in the therapeutic community (TC) with the Dimensions of Change Instrument (DCI).
• Modulation of membrane channel currents by gap junction protein mimetic peptides: size matters.
• Molecular characterization of a novel X-linked syndrome involving developmental delay and deafness.
• Nanosized (mu12-Pt)Pd164-xPtx(CO)72(PPh3)20 (x approximately 7) containing Pt-centered four-shell 165-atom Pd-Pt core with unprecedented intershell bridging carbonyl ligands: comparative analysis of icosahedral shell-growth patterns with geometrically rel
• Neural systems of positive affect: relevance to understanding child and adolescent depression?
• Resilience among children and adolescents at risk for depression: Mediation and moderation across social and neurobiological contexts.
• Single-dosage pharmacokinetics of sodium ferric gluconate complex in iron-deficient pediatric hemodialysis patients.
• Sleep and the developing brain.
• Sleeplessness and aggression in youth.
• The relationship between coping strategies and anxiety in women from families with familial breast-ovarian cancer in the absence of demonstrated mutations.
• Vectors using the phospho-alpha-(1,1)-glucosidase-encoding gene treA of Bacillus subtilis as a reporter.
• Vincent's infection.
• Young survivors of malignant bone tumours in the extremities: a comparative study of quality of life, fatigue and mental distress.
• [Adjuvant chemotherapy for colon cancer.]
• [In Process Citation]